| John D Wagel, MD | |
|
1316 E 7th St, Auburn, IN 46706-2523 | |
| (260) 925-4600 | |
| Not Available |
| Full Name | John D Wagel |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1316 E 7th St, Auburn, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487630414 | NPI | - | NPPES |
| P00266379 | Other | IN | RAILROAD MEDICARE |
| 100318150A | Medicaid | IN | |
| 0000372545 | Other | IN | BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 01040117A (Indiana) | Primary |
| Entity Name | Adams County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689696148 PECOS PAC ID: 0941198253 Enrollment ID: O20041001000326 |
News Archive
PTC Therapeutics, Inc. today announced that following its request for re-examination, the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) in ambulatory patients aged five years and older.
A study published today in the BMJ Open shows that in countries where there is a complete ban on all corporal punishment of children there is less fighting among young people.
Cataldo Doria, M.D., Ph.D., F.A.C.S., director, Division of Transplant Surgery, in the Department of Surgery at Thomas Jefferson University Hospital, has been named the Nicoletti Family Professor of Transplant Surgery. This endowed professorship is a generous gift of Robert and Beatrice Nicoletti and their family. The family cited the care they received at Jefferson when Robert received a new kidney donated by his own daughter, as the reason for their donation.
Onconova Therapeutics, Inc. today announced promising results from two clinical trials in patients with advanced Myelodysplastic Syndrome (MDS) treated with ON 01910.Na. These trials are being conducted at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD, and St. Vincent's Comprehensive Cancer Center in New York.
A 12-year study led by a team of University of Arizona Cancer Center researchers is bringing into question the safety and efficacy of selenium, a popular nutritional supplement touted to combat and reduce the risk of colorectal cancer.
› Verified 8 days ago
| Entity Name | Community Hospital Of Lagrange County, Inc. |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1679674956 PECOS PAC ID: 1355382706 Enrollment ID: O20140318000136 |
News Archive
PTC Therapeutics, Inc. today announced that following its request for re-examination, the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) in ambulatory patients aged five years and older.
A study published today in the BMJ Open shows that in countries where there is a complete ban on all corporal punishment of children there is less fighting among young people.
Cataldo Doria, M.D., Ph.D., F.A.C.S., director, Division of Transplant Surgery, in the Department of Surgery at Thomas Jefferson University Hospital, has been named the Nicoletti Family Professor of Transplant Surgery. This endowed professorship is a generous gift of Robert and Beatrice Nicoletti and their family. The family cited the care they received at Jefferson when Robert received a new kidney donated by his own daughter, as the reason for their donation.
Onconova Therapeutics, Inc. today announced promising results from two clinical trials in patients with advanced Myelodysplastic Syndrome (MDS) treated with ON 01910.Na. These trials are being conducted at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD, and St. Vincent's Comprehensive Cancer Center in New York.
A 12-year study led by a team of University of Arizona Cancer Center researchers is bringing into question the safety and efficacy of selenium, a popular nutritional supplement touted to combat and reduce the risk of colorectal cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John D Wagel, MD # 774560, 4560 Solutions Center, Chicago, IL 60677-4005 Ph: (260) 969-1950 | John D Wagel, MD 1316 E 7th St, Auburn, IN 46706-2523 Ph: (260) 925-4600 |
News Archive
PTC Therapeutics, Inc. today announced that following its request for re-examination, the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the company's application for a conditional marketing authorization of Translarna (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) in ambulatory patients aged five years and older.
A study published today in the BMJ Open shows that in countries where there is a complete ban on all corporal punishment of children there is less fighting among young people.
Cataldo Doria, M.D., Ph.D., F.A.C.S., director, Division of Transplant Surgery, in the Department of Surgery at Thomas Jefferson University Hospital, has been named the Nicoletti Family Professor of Transplant Surgery. This endowed professorship is a generous gift of Robert and Beatrice Nicoletti and their family. The family cited the care they received at Jefferson when Robert received a new kidney donated by his own daughter, as the reason for their donation.
Onconova Therapeutics, Inc. today announced promising results from two clinical trials in patients with advanced Myelodysplastic Syndrome (MDS) treated with ON 01910.Na. These trials are being conducted at the National Heart, Lung, and Blood Institute (NHLBI) in Bethesda, MD, and St. Vincent's Comprehensive Cancer Center in New York.
A 12-year study led by a team of University of Arizona Cancer Center researchers is bringing into question the safety and efficacy of selenium, a popular nutritional supplement touted to combat and reduce the risk of colorectal cancer.
› Verified 8 days ago
Keith R Schreffler Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1316 E 7th St, Auburn, IN 46706 Phone: 260-925-4600 | |
Ajiru S Nyambwa, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1316 E 7th St, Auburn, IN 46706 Phone: 260-925-4600 Fax: 260-482-4442 | |
Tiffany Carolyn Alexander, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1316 E 7th St, Auburn, IN 46706 Phone: 260-925-4600 | |
James Lebamoff, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1316 E 7th St, Auburn, IN 46706 Phone: 260-925-4600 |